pharmtech.com rank 421 |
Number of domains linking to pharmtech.com 1 | semantic flow 0.06 |
Number of links to pharmtech.com 1 | semantic flow 0.06 |
Number of domains linked from pharmtech.com 13 | semantic flow 1.6 |
Number of links from pharmtech.com 25 | semantic flow 1.6 |
On-topic pages from domain with highest topical PageRank.
title / url | |
---|---|
Storm Impact on Drug Supply | Pharmaceutical Technology http://www.pharmtech.com/storm-impact-drug-supply | |
FDA to Recognize Inspections from EU Drug Authorities | Pharmaceutical Technology http://www.pharmtech.com/fda-recognize-inspections-eu-drug-authorities | |
The Evolving War on Drug Prices | Pharmaceutical Technology http://www.pharmtech.com/evolving-war-drug-prices-0 |
On-topic pages from domain with highest topical PageRank having a few outgoing links and domains.
title / url | |||||||||
---|---|---|---|---|---|---|---|---|---|
The Evolving War on Drug Prices | Pharmaceutical Technology http://www.pharmtech.com/evolving-war-drug-prices-0 | 0.19 | 1 | 123 | 23 | 10 | 10 | 0 | 0 |
Relevant domains with most links to selected domain.
domain | |||
---|---|---|---|
http://nih.gov/ | 1 | 0.06 | nih.gov |
Relevant domains with most links from selected domain.
Pages from domain with most relevant inbound links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
http://www.pharmtech.com/drug-pricing-dominates-senate-hearing-hhs-nominee-azar-0 | 1 | 0.16 | 0.63 | 0.01 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
http://www.pharmtech.com/assessing-product-integrity-risk-profiles-and-engineering-dose-au | 1 | 0.16 | 0.89 | 0.01 | 1 | yes | 105 | 14 | 1 | 1 | 0 | 0 | |
http://www.pharmtech.com/resurgence-natural-product-based-drug-discovery | 1 | 0.16 | 0.63 | 0.01 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
http://www.pharmtech.com/pharmtech-rss-and-linking-policy | 1 | 0.16 | 0.91 | 0.01 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
http://www.pharmtech.com/enhancing-solubility-poorly-soluble-drugs | 1 | 0.16 | 0.62 | 0.01 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
http://www.pharmtech.com/tackling-opioid-crisis-abuse-deterrent-formulations | 1 | 0.16 | 0.62 | 0.01 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
http://www.pharmtech.com/fda-heads-back-work-now | 1 | 0.16 | 0.61 | 0.01 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
http://www.pharmtech.com/standard-terms-and-conditions-advertising | 1 | 0.16 | 0.88 | 0.01 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
http://www.pharmtech.com/pharmtech-news | 1 | 0.16 | 0.83 | 0.01 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
http://www.pharmtech.com/pharmaceutical-technology-08-01-2017 | 1 | 0.16 | 0.77 | 0.01 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 |
Pages from domain with most likely on-topic outgoing links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
http://www.pharmtech.com/ | 13 | 0.15 | 0.28 | 0.17 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
http://www.pharmtech.com/evolving-war-drug-prices-0 | 8 | 0.19 | 0.88 | 0.57 | 1 | yes | 123 | 23 | 10 | 10 | 0 | 0 | |
http://www.pharmtech.com/fda-new-drug-approvals-down-significantly-2016 | 8 | 0.17 | 0.86 | 0.55 | 1 | yes | 115 | 22 | 7 | 3 | 0 | 0 | |
http://www.pharmtech.com/expediting-discovery-and-development-drugs | 8 | 0.15 | 0.87 | 0.35 | 1 | yes | 107 | 15 | 1 | 1 | 0 | 0 | |
http://www.pharmtech.com/expedited-approvals-and-orphan-drugs-dominated-2015-novel-new-dru | 4 | 0.17 | 0.9 | 0.26 | 1 | yes | 109 | 19 | 4 | 2 | 0 | 0 | |
http://www.pharmtech.com/outlook-bright-branded-and-generic-active-ingredients | 3 | 0.18 | 0.88 | 0.21 | 1 | yes | 110 | 17 | 3 | 2 | 0 | 0 | |
http://www.pharmtech.com/global-report-1 | 3 | 0.17 | 0.89 | 0.19 | 1 | yes | 118 | 17 | 1 | 1 | 0 | 0 | |
http://www.pharmtech.com/drug-quality-key-innovation-and-access | 3 | 0.17 | 0.9 | 0.19 | 1 | yes | 107 | 17 | 4 | 3 | 0 | 0 | |
http://www.pharmtech.com/enhancing-new-drug-development | 2 | 0.18 | 0.89 | 0.1 | 1 | yes | 109 | 16 | 2 | 2 | 0 | 0 | |
http://www.pharmtech.com/fda-recognize-inspections-eu-drug-authorities | 1 | 0.19 | 0.88 | 0.07 | 1 | yes | 104 | 15 | 2 | 2 | 0 | 0 |
Similar domains to domain, based on inbound linking patterns from other relevant domains. This is also known in SEO as topical co-citation.